The price will actually go down after a brief UK approval spike and that too if we are lucky. The stock will be at all time lows in a few months post UK approval as LP continues her disappointing dilution streak.
Also, the cycle of disappointing quarterly revenues from UK will continue for many years while the outstanding share count touches 3B in a couple of years.
Doc Logic will be blaming Flaskworks and manufacturing for lack of reimbursement support in 2027. Gary will be pumping for a 20 cent share price while we are trading at 3-4 cents in 2028.
Market Data 
Markets 
AI
